Molecular Insight Pharmaceuticals competitive analysis

Latest publications and patents of Molecular Insight Pharmaceuticals New

Explore the latest publications and patents granted to Molecular Insight Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 24, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Molecular Insight Pharmaceuticals

Jun 29, 2022Heterodimers Of Glutamic AcidGranted And Under Opposition
Dec 30, 2020Heterodimers Of Glutamic AcidRevoked

Explore Molecular Insight Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jun 29, 2022Heterodimers Of Glutamic Acid1
Dec 30, 2020Heterodimers Of Glutamic Acid3

Latest PTAB cases involving Molecular Insight Pharmaceuticals

Discover the latest PTAB cases involving Molecular Insight Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 30, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Molecular Insight Pharmaceuticals

PGR2021-00048Feb 4, 2021ADVANCED ACCELERATOR APPLICATIONS USAMOLECULAR INSIGHT PHARMACEUTICALSTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Molecular Insight Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
MOLECULAR INSIGHT PHARMACEUTICALS - 4 - 1Non-Active
ADVANCED ACCELERATOR APPLICATIONS USA - - 1 - Highly Aggressive
DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS UNIVERSITAT HEIDELBERG1 - - - Highly Aggressive
LEWIS SILKIN2 - - - Highly Aggressive